thymidine has been researched along with mitoxantrone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chitnis, MP; Juvekar, AS | 1 |
| Advani, SH; Chitnis, MP; Parekh, HK | 1 |
| Advani, SH; Chitnis, MP; Pradhan, SG; Satyamoorthy, K | 1 |
| Advani, SH; Adwankar, MK; Chitnis, MP; Juvekar, AS | 1 |
| Chitnis, MP; Kamath, NS | 1 |
| Chegini, N; Safa, AR; Tseng, MT | 1 |
| Andreola, S; Benini, E; Brambilla, C; Daidone, MG; Ferrari, L; Greco, M; Luisi, A; Mastore, M; Silvestrini, R; Veneroni, S | 1 |
| Behrens, CH; Behrens, DL; Chen, SF; Fredericks, JR; Kirshenbaum, MR; Papp, LM; Polkus, ST; Sipple, P; Stafford, MM; Sun, JH | 1 |
| Abubakar, AA; Riches, AC | 1 |
| Tian, Y; Wang, H; Yang, P; Zhang, Z; Zhao, C | 1 |
| Holguin, MH; Morgan, CD | 1 |
| Archelos, JJ; Hartung, HP; Hemmer, B; Kieseier, BC; Neuhaus, O; Stüve, O; Wiendl, H | 1 |
1 trial(s) available for thymidine and mitoxantrone
| Article | Year |
|---|---|
Changes in biological markers after primary chemotherapy for breast cancers.
Topics: Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cell Cycle; Cell Division; Cyclophosphamide; Diploidy; DNA, Neoplasm; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Mitoxantrone; Neoplasm Staging; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; S Phase; Thymidine; Tumor Suppressor Protein p53 | 1995 |
11 other study(ies) available for thymidine and mitoxantrone
| Article | Year |
|---|---|
Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Resistance; Hyperthermia, Induced; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitoxantrone; Thymidine; Tumor Cells, Cultured | 1991 |
Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine.
Topics: Cell Survival; DNA Replication; DNA, Neoplasm; Doxorubicin; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitoxantrone; Quinidine; Thymidine; Tumor Cells, Cultured | 1990 |
Modulation of sensitivity to mitoxantrone in human chronic myeloid leukemia cells by the antidepressant sintamil.
Topics: Antidepressive Agents, Tricyclic; Colony-Forming Units Assay; Dibenzoxazepines; DNA Replication; Drug Synergism; Humans; Leukemia, Myeloid; Mitoxantrone; Thymidine; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1988 |
Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia.
Topics: Antineoplastic Agents; Cell Survival; Combined Modality Therapy; DNA Replication; Hot Temperature; Humans; In Vitro Techniques; Leukemia, Myeloid; Mitoxantrone; Thymidine | 1986 |
Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
Topics: Aminopyrine; Animals; Dipyrone; DNA; Doxorubicin; Drug Resistance; Drug Synergism; Leukemia P388; Leukemia, Experimental; Mice; Mitoxantrone; Thymidine; Tumor Stem Cell Assay | 1987 |
Influence of mitoxantrone on nucleic acid synthesis on the T-47D breast tumor cell line.
Topics: Anthraquinones; Breast Neoplasms; Cell Line; Cells, Cultured; DNA, Neoplasm; Female; Humans; Mitoxantrone; RNA, Neoplasm; Thymidine; Tritium; Uridine | 1983 |
(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Isoquinolines; KB Cells; Kinetics; Leucine; Leukemia L1210; Leukemia P388; Mammary Neoplasms, Experimental; Melanoma; Melanoma, Experimental; Mesylates; Mice; Mitoxantrone; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured; Uridine | 1994 |
A possible correlation between growth-factor sensitivity and response to mitoxantrone treatment in a murine myeloid leukaemia (SA7HD) cell line.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Count; Cell Division; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Growth Substances; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mice, Inbred CBA; Mice, Inbred Strains; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Transplantation; Radiopharmaceuticals; Thymidine; Tritium; Tumor Cells, Cultured | 1997 |
Experimental antitumor activity of the Ce(IV)-mitoxantrone complex and its interaction with deoxyribonucleic acid.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cerium; Circular Dichroism; DNA; DNA, Neoplasm; Drug Screening Assays, Antitumor; Electrochemistry; Electrophoresis; Mice; Mitoxantrone; Organometallic Compounds; Spectrophotometry; Thymidine; Tumor Cells, Cultured; Ultraviolet Rays | 1997 |
Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.
Topics: Antibiotics, Antineoplastic; Antibodies, Blocking; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Bleomycin; Dactinomycin; Dose-Response Relationship, Drug; Humans; Immunophenotyping; Lectins, C-Type; Mannitol; Mitomycin; Mitoxantrone; Plicamycin; Spectrometry, Fluorescence; Stress, Physiological; T-Lymphocytes; Thymidine | 2002 |
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Topics: Adult; Annexin A5; Blood Cells; Cell Death; Cell Differentiation; Cells, Cultured; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Gene Expression; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Matrix Metalloproteinases; Mitoxantrone; Multiple Sclerosis; Neurotoxins; Propidium; T-Lymphocytes; Tetanus Toxin; Thymidine; Tritium | 2005 |